Related Experiment Video

Updated: Aug 11, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia

N Tomita1, S Motomura, Y Ishigatsubo

  • 1Department of Hematology, Fujieda Municipal General Hospital, Shizuoka, Japan. n-tomita@tf6.so-net.ne.jp

Anti-Cancer Drugs
|March 29, 2001
PubMed

Insights

Interferon (IFN)-alpha therapy for chronic myelogenous leukemia can cause pure red cell aplasia (PRCA). Discontinuing IFN-alpha treatment led to PRCA improvement, suggesting its role in the condition.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm.
  • Interferon (IFN)-alpha is a therapeutic agent used in CML treatment.
  • Pure red cell aplasia (PRCA) is a rare anemia characterized by the selective absence of erythroid precursors in the bone marrow.

Observation:

  • A patient undergoing interferon (IFN)-alpha therapy for chronic myelogenous leukemia developed pure red cell aplasia (PRCA).
  • The PRCA resolved spontaneously within one month after the cessation of IFN-alpha treatment.

Findings:

  • The clinical course suggests a direct link between interferon (IFN)-alpha administration and the development of pure red cell aplasia (PRCA).
  • This case highlights a potential adverse effect of IFN-alpha therapy.

Implications:

  • Interferon (IFN)-alpha may play a role in the pathogenesis of pure red cell aplasia (PRCA).
  • Clinicians should consider IFN-alpha-induced PRCA in patients with CML presenting with unexplained anemia.
  • Further investigation into the mechanisms of IFN-alpha-induced hematotoxicity is warranted.

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...